In a real-world study, dose reductions of an FDA-approved therapy for pancreatic cancer were effective and associated with improved clinical outcomes in the treatment of advanced disease.

Read more: https://www.docwirenews.com/docwire-pick/reduced-dose-effective-for-treatment-of-advanced-pancreatic-cancer/